Helmholtz Centre for Infection Research admet, supply/service news

Helmholtz spun off its Screenflex and CI-Screen assets into newco InScreeneX GmbH. InScreeneX will develop customized cells for biopharmaceutical companies for use in drug discovery. The newco has exc...